Cancer disease progression and death during the COVID-19 pandemic: A multidisciplinary analysis for the Peruvian setting

Astigueta-Pérez J.; Abad-Licham M.; Chávez-Chirinos C.; Beraun-Milla L.; Lachos-Dávila A.; Diaz-Pérez E.; Portugal-Valdivia K.; Castañeda P.P.; Alférez I.P.; Mezones-Holguín E. · ecancermedicalscience (2020) · DOI: 10.3332/ecancer.2020.1098

Resumen

Since the COVID-19 pandemic began in China in late 2019, infection from the SARSCoV-2 virus has spread virtually worldwide. This infection has adversely affected several countries; governments have outlined a series of political measures aimed to preserve the health and safety of their populations. In Peru, most actions have prioritised COVID-19 attention, with a subsequent gap in the healthcare facilities needed for other diseases. Cancer, one principal cause of death in the country, is usually diagnosed late. Moreover, in the pandemic context, the prevention and control of cancer have been negatively affected. Therefore, we carried out a multidisciplinary analysis using the Ishikawa diagram to identify the probable factors that contribute to cancer progression and deaths in Peru. Copyright: © the authors; licensee ecancermedicalscience. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Instituciones: Universidad Privada Antenor Orrego; Universidad San Ignacio de Loyola; Universidad Nacional Jorge Basadre Grohmann